FDA Advisers Recommend Approving Weight Loss Drug

Posted Thursday, May 10, 2012 --- 3:40 p.m.

WASHINGTON (AP) -- Advisers to government health regulators have recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.

A panel of expert advisers to the Food and Drug Administration voted 18-4 to recommend approval of lorcaserin, developed by Arena Pharmaceuticals Inc. They concluded that its benefits "outweigh the potential risks when used long term" in overweight and obese people. One panel member abstained from voting.

Lorcaserin is one of three experimental weight-loss drugs whose developers have been trying for a second time to get approved, after the FDA shot them all down in 2010 or early 2011.

Copyright 2012. The Associated Press.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
NBC15 615 Forward Drive Madison, Wisconsin 53711 Business: 608-274-1515 Newsroom: 608-274-1500
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 151009465 - nbc15.com/a?a=151009465